Washington University School of Medicine in St. Louis and Caeli Vascular, Inc., are developing the first sequestered therapy device for removal of deep vein thrombosis.
$2 Million Grant to Develop Sequestered Vascular Surgery Technology

Washington University School of Medicine in St. Louis and Caeli Vascular, Inc., are developing the first sequestered therapy device for removal of deep vein thrombosis.
Washington University vascular surgeons answer patient questions regarding deep vein thrombosis.